Their Patented Comfort Channel is taking the sleep industry by storm by molding uniquely to each sleeper.
LOS ANGELES , Feb. 1, 2022 /PRNewswire-PRWeb/ -- SONU Sleep was founded by business partners and friends, Stason Strong and Brad Hall , to solve the problem of arm, shoulder, and neck discomfort for side sleepers. This raises the question; "The human body is not flat, so why do we all sleep on flat mattresses?"
Many factors go into the quality and effectiveness of a night's rest - comfort, temperature, noise, and stress levels all play large roles in a sleeper's abilities the following day. As noise and stress levels are only solved on a case-by-case basis, the founders set their sights on extreme physical comfort by researching the reasons most sleepers never attain motionless slumber with an optimal sleeping position that lasts through the night. The problem has quite literally been right under us the entire time - the traditional flat mattress.
After much research, countless development iterations, and thorough testing, Stason and Brad have pinpointed the problems with the traditional flat mattress design... and solved them. The SONU Sleep System was born. Never before have sleepers been able to fully immerse into the mattress. The patented Comfort Channel and layered Support Pillow system allow for the full range of motion of shoulders and arms within the bed, not just on top. Molding to the sleeper's unique shape and desired position, the system greatly reduces pressures that have long been thought to be unavoidable. Couples enjoy sleeping and embracing without undesirable pressure on arms caused by traditional mattresses.
Side-sleepers can now benefit from not needing to roll over to relieve pressure on arms and shoulders constantly, resulting in sound sleep throughout the night. Joint and muscle pain, chronic discomfort, and injuries in the neck, arms, shoulders, and chest can be greatly reduced by SONU's unique immersive support system. The sides of the Comfort Channel also act as hand supports when holding a device or book, reducing hand and wrist tension when reading and watching. Sleepers who snore on their backs can finally roll to the side to help alleviate snoring without the discomfort traditionally experienced. The founders identified each of these goals and created the SONU Sleep System to address them all.
The founders and the entire team at SONU Sleep now invite consumers to experience an entirely new world of relieving rest and satisfying comfort. It is finally time to sleep like never before.
SONU launches on February 15th, 2022 and ships nationwide, bringing a new standard of comfort from coast to coast.
The name "SONU" was derived from the word "sono" which means "slumber" in Portuguese. While Stason was in Brazil in 2014, he first came up with the idea of a bed that allows sleepers' limbs to immerse into the mattress to alleviate discomfort and elevate the quality of rest. Years later, after teaming up and perfecting the design, Stason and Brad named the company "SONU", commemorating the location of the idea's first inception, with the root word in Portuguese, while swapping in the letter "U" to create their own unique ending to symbolize the shape of the SONU Sleep System's patented Comfort Channel.
GR0 Agency, GR0, (310) 439-1887, press@gr0.com
What happened Shares of drugmaker Novavax (NASDAQ: NVAX) are up to the tune of 18.9% as of 2:11 p.m. ET Friday, according to data from S&P Global Market Intelligence, thanks to a confluence of events that work in the company's favor.
The Dow Jones rallied amid encouraging inflation data. Tesla stock jumped even as CEO Elon Musk issued a warning. Apple stock surged.
Despite all the attention that renewable energy companies get, having operations in the renewable energy space alone does not make a stock a buy. In fact, several renewable energy companies are struggling just to stay profitable. Let's discuss two renewable energy stocks that look attractive right now, and one that's best avoided.
Stop investing in mediocre businesses. Buy the best, instead.
Shareholders in Amazon (NASDAQ: AMZN) beat a rising market on Friday morning, with shares gaining 3% by 10:45 a.m. ET compared to a 1.4% boost in the S&P 500. The rally was powered by a brightening outlook around economic growth and consumer spending. A major factor driving Amazon's stock higher on Friday was the boost in the wider tech world.
Shares of Moderna (NASDAQ: MRNA) were jumping 7.5% higher as of 11:30 a.m. ET on Friday. Instead, Moderna appears to be benefiting from the overall stock market bounce. Good news for the overall stock market tends to be good news for Moderna.
Theme parks, streaming services, and multiplexes are hoping the next few months are lucrative, and Walt Disney (NYSE: DIS), Netflix (NASDAQ: NFLX), and AMC Entertainment Holdings (NYSE: AMC) feel that there is no time like the present. A popular series is back with a new season -- part of a new season, anyway -- on Netflix. AMC hopes that the reboot of a classic action franchise will kick off a promising summer season.
Ulta shares are up after its big Q1 earnings beat, Aurora Cannabis increased its finance deal to $150 million, and Blackberry stock is surging after news of its partnership with Google.
Shares of Iovance Biotherapeutics (NASDAQ: IOVA) are down 53% as of 12:24 p.m. ET Friday, according to data from S&P Global Market Intelligence, following the release of disappointing results from a pivotal melanoma drug trial released Thursday evening. Iovance had already reported solid results for melanoma treatment Lifileucel in the middle of last year, ultimately finding a response rate of 36%. This follow-on study of cancer patients with advanced melanoma who had shown improvement after previously receiving and responding to anti-PD-1/L1 therapies isn't as encouraging, with an objective response rate of only 29%.
Mirati is unlikely to carve out a share of the lung cancer market, analysts said Friday as MRTX stock collapsed on a testing disappointment.
Julian Bridgen, co-founder and president of Macro Intelligence 2 Partners, joins Yahoo Finance Live to discuss this week's market action and whether or not it will carry over into next week, the Fed, and inflation.
In this article, we discuss the 10 stocks that Jim Cramer and hedge funds agree on. If you want to read about some more stocks that Jim Cramer and hedge funds agree on, go directly to Jim Cramer and Hedge Funds Agree on These 5 Stocks. In the past few weeks, Jim Cramer, the journalist […]
Risk and reward are the yin and yang of stock trading, the two opposite but essential ingredients in every market success. And there are no stocks that better embody both sides – the risk factors and the reward potentials – than penny stocks. These equities, priced below $5 per share, typically offer high upside potentials. Even a small gain in share price – just a few cents – quickly translates into a high yield return. Of course, the risk is real, too; not every penny stock is going to show th
Stock splits have been all the rage in recent years, fueled by surging stock prices of some of the world's most recognizable companies. Worse still, the tech-heavy Nasdaq has tumbled into bear market territory, down roughly 27% from its high reached late last year. Read on to find out why they picked Amazon (NASDAQ: AMZN), Alphabet (NASDAQ: GOOGL) (NASDAQ: GOOG), and Shopify (NYSE: SHOP) from among the recent stock-split candidates.
In this article, we will look at 10 undervalued stocks to buy according to billionaire Leon Cooperman. If you want to skip reading about Leon Cooperman’s early life, investment philosophy, and his hedge fund’s performance, you can go directly to 5 Undervalued Stocks to Buy According to Billionaire Leon Cooperman. Leon Cooperman is an American […]
The stock market selloff has made many stocks look cheap—but smart investors need to be selective. Here are six high-quality companies that trade at reasonable valuations.
Qualcomm CEO Cristiano Amon weighs in on the outlook for the semiconductor industry and his company's future.
Choosing between two depends on whether you'd rather pay taxes now, or later.
A key measure of U.S. inflation rose just 0.2% in April to mark the smallest increase in a year and a half, aided by lower gas prices. Yet there were other hints that a surge in U.S. inflation might be abating.
The cannabis company's per-share loss was almost five times as big as analysts had expected. The stock plunged in response.